| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/22/2001 | EP1124813A1 Microbial transformation product |
| 08/22/2001 | EP1124811A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 08/22/2001 | EP1124810A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 08/22/2001 | EP1124809A1 Benzoylpyridazines |
| 08/22/2001 | EP1124806A2 Use of n-substituted (3,6-dihydro)-2h-1,2-oxazine derivatives as selective mglur1 antagonists |
| 08/22/2001 | EP1124804A1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors |
| 08/22/2001 | EP1124801A1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 08/22/2001 | EP1124797A1 N-arylsulfonyl amino acid omega amides |
| 08/22/2001 | EP1124794A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 08/22/2001 | EP1124788A2 Bis(haloethyl)aminobenzene derivatives |
| 08/22/2001 | EP1124779A1 Vitamin d analogues |
| 08/22/2001 | EP1124580A1 Enhanced radiation therapy |
| 08/22/2001 | EP1124572A2 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 08/22/2001 | EP1124568A1 Polyspecific binding molecules and uses thereof |
| 08/22/2001 | EP1124567A2 Buffered compositions for dialysis |
| 08/22/2001 | EP1124566A1 Non-fermented osmotic laxative for treating and preventing colorectal cancers |
| 08/22/2001 | EP1124565A1 Beta-l-2'-deoxy-nucleosides for the treatment of hiv infection |
| 08/22/2001 | EP1124564A1 Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases |
| 08/22/2001 | EP1124563A2 Methods and compositions for the prevention of tolerance to medications |
| 08/22/2001 | EP1124562A1 Combination therapy to treat hepatitis b virus |
| 08/22/2001 | EP1124561A1 Compositions comprising a mixture of bioflavonols |
| 08/22/2001 | EP1124560A1 Use of antifungal agents for treating scleroses |
| 08/22/2001 | EP1124559A1 Compositions for the treatment and prevention of neurological and pathopsychological diseases |
| 08/22/2001 | EP1124558A2 A novel inhibitor of cataract formation |
| 08/22/2001 | EP1124557A2 Pharmaceutical composition |
| 08/22/2001 | EP1124556A1 Use of optically pure (r)-tofisopam for treating and preventing anxiety disorders and composition thereof |
| 08/22/2001 | EP1124555A1 Method of treating neurodegenerative diseases |
| 08/22/2001 | EP1124554A1 Pharmaceutical compositions containing tetrahydroisoquinoline compounds |
| 08/22/2001 | EP1124553A1 New use of glutamate antagonists for the treatment of cancer |
| 08/22/2001 | EP1124552A1 Antitumor chrysene derivatives |
| 08/22/2001 | EP1124551A2 Delta 9 tetrahydrocannabinol (delta 9 thc) solution metered dose inhalers and methods of use |
| 08/22/2001 | EP1124550A1 Methods and compositions for selective cancer chemotherapy |
| 08/22/2001 | EP1124549A1 Water-miscible pharmaceutical compositions of paclitaxel |
| 08/22/2001 | EP1124548A2 Compositions for the treatment and prevention of cardiovascular diseases |
| 08/22/2001 | EP1124547A1 Pharmaceutical combination of mildronate and enalapril |
| 08/22/2001 | EP1124546A2 Use of hyaluronic acid for the treatment of radiation cystitis |
| 08/22/2001 | EP1124545A2 Use of estrogenic compounds as anti-fungal agents |
| 08/22/2001 | EP1124544A1 Dry powder pharmaceutical formulation |
| 08/22/2001 | EP1124543A1 Controlled release formulation for water soluble drugs |
| 08/22/2001 | EP1124541A1 Application of water-soluble or water-dispersible polymerizates which contain poly-ether and which are used as a coating agent, a binding agent and/or as a film-forming auxiliary agent in pharmaceutical forms of administration |
| 08/22/2001 | EP1124539A1 Pharmaceutical formulation comprising omeprazole |
| 08/22/2001 | EP1124537A1 Propofol composition |
| 08/22/2001 | EP1124536A1 Propofol composition comprising pentetate |
| 08/22/2001 | EP1124531A1 Reduction of hair growth |
| 08/22/2001 | EP1124528A1 Multivalent macrolide antibiotics |
| 08/22/2001 | EP1124418A1 Use of gm-csf to inhibit development of drug resistance in hiv+ patients |
| 08/22/2001 | EP1124416A1 Treatment of acute headaches and chronic pain using rapidly-cleared anesthetic drug at sub-anesthetic dosages |
| 08/22/2001 | EP1105518A4 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS |
| 08/22/2001 | EP0991402A4 Poly(vinyl alcohol) cryogel |
| 08/22/2001 | EP0907633B1 New synthetic catechol derivatives, method for production and use thereof |
| 08/22/2001 | EP0904042A4 Cosmetic composition for rejuvenation of skin without skin irritation |
| 08/22/2001 | EP0876361B1 4,10beta-diacetoxy-2alpha-benzoyloxy-5beta,20-epoxy-1-hydroxy-9-oxo-19-nor-cyclopropa(g]tax-11-ene-13alpha-yl (2r,3s)-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate dihydrate, and method for preparing same |
| 08/22/2001 | EP0836472B1 Therapeutic effervescent compositions |
| 08/22/2001 | EP0833611B1 A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof |
| 08/22/2001 | EP0825871B1 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids |
| 08/22/2001 | EP0824536B1 Antimalarial organometallic iron complexes |
| 08/22/2001 | EP0809516B1 Medicinal combination useful for in vivo exogenic transfection and expression |
| 08/22/2001 | EP0799210B1 Piperazine-2,5-dione derivatives as modulators of multidrug resistance |
| 08/22/2001 | EP0785926B1 Carboxylic acid derivatives, their preparation and their use as medicaments |
| 08/22/2001 | EP0777653B1 Dihygropyridine derivatives as bradykinin antagonists |
| 08/22/2001 | EP0752854B1 Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments |
| 08/22/2001 | EP0696208B1 Oral drug delivery compositions |
| 08/22/2001 | EP0626851B1 Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the preparation of a medicament for the treatment of certain types of pain and of oedema |
| 08/22/2001 | EP0563336B1 Pharmaceutical composition containing gamma-hydroxybutyric acid or its lactone in the treatment of drug dependence and nutritional disorders |
| 08/22/2001 | CN1309706A Compound from moraxella catarrhalis |
| 08/22/2001 | CN1309666A Polymer composition of glucuronic acid glucosan |
| 08/22/2001 | CN1309660A Phosphinous and phosphonic acid derivs. used as medicaments |
| 08/22/2001 | CN1309659A Phosphorous organic compounds and their use |
| 08/22/2001 | CN1309657A Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of growth hormone release inhibiting factor receptors |
| 08/22/2001 | CN1309656A Thioalkyl alpha-substd. pyrimidine compounds |
| 08/22/2001 | CN1309655A Cyclic compounds useful in treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process |
| 08/22/2001 | CN1309654A Biphenyl derivs. |
| 08/22/2001 | CN1309653A Polycyclic thiazolidin-2-ylidene amines, method for production and use thereof as medicaments |
| 08/22/2001 | CN1309651A Morpholino ethers |
| 08/22/2001 | CN1309649A Polyhydroalkylpyrazine derivs. and their preparation and medicines contg. them |
| 08/22/2001 | CN1309648A Piperazinone derivs. and their uses |
| 08/22/2001 | CN1309645A Biphenylsulfonyl-substd. imidazole derivs., their preparation process, their use as drug or diagnostic agent |
| 08/22/2001 | CN1309644A Biphenylsulfonyl-substd. imidazole derivs., their preparation process, their use as drug or diagnostic agent and drug contg. them |
| 08/22/2001 | CN1309642A Novel 1,2,5-trisubstd. 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effects, method for production and use as medicam ent |
| 08/22/2001 | CN1309641A Quinoline derivs. |
| 08/22/2001 | CN1309640A Quinoline derivs. |
| 08/22/2001 | CN1309639A Pharmaceutical compositions comprising 2-quinolones |
| 08/22/2001 | CN1309638A N-substd. naphthalene carboxamides as neurokinin-receptor antagonists |
| 08/22/2001 | CN1309637A Compositions comprising 2-phenyl-indole compounds and estrogen formutations |
| 08/22/2001 | CN1309635A Benzocycloheptenes, method for production thereof, pharmaceutical preparations contg. these compounds, and their use for producing medicaments |
| 08/22/2001 | CN1309634A Hydrazine derivs. |
| 08/22/2001 | CN1309633A Diacylhydrazine derivs. as integrain inhibitors |
| 08/22/2001 | CN1309631A Aminomethylcarboxylic acid derivs |
| 08/22/2001 | CN1309569A Composition comprising tumor cells and extracts and method for using thereof |
| 08/22/2001 | CN1309568A Combination therapy comprising ribavirin and interferon alpha in antiviral treatment naive patients having G chronic hepatitis C infection |
| 08/22/2001 | CN1309566A Nocathiacin antibiotics |
| 08/22/2001 | CN1309565A Pharmaceutical composition for treating or preventing sleep disorders |
| 08/22/2001 | CN1309564A Method of treatment |
| 08/22/2001 | CN1309563A Use of 1-(aminoalkyl)-3-quinoxaline-2-one derives for preparation of compounds having antioxidant action |
| 08/22/2001 | CN1309562A Topical compositions comprising opioid analgesic and NMDA antagonist |
| 08/22/2001 | CN1309561A Therapeutic agent for erection failure |
| 08/22/2001 | CN1309560A Prevention of migraine recurrence |
| 08/22/2001 | CN1309559A Synthetically prepared hydroxy citric acid composition for treatment and/or propylaxis of overweight and use thereof |
| 08/22/2001 | CN1309558A Transdermal patch and topical compositions comprising propylnorapomorphine |
| 08/22/2001 | CN1309557A Formulation contg. paroxetine |